| |
 |
|
Class Information
Number: 514/43
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring
Description: Subject matter wherein the aglycone portion contains a nitrogen containing hetero ring.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/52 |
Phosphorus containing (e.g., vitamin b12, etc.) |
258 |
| 514/44 |
Polynucleotide (e.g., rna, dna, etc.) |
3,242 |
| 514/45 |
Purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
540 |
| 514/49 |
Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
504 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6703373 |
Indolopyrrolocarbazole derivatives and antitumor agents |
Mar. 9, 2004 |
| 6689759 |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
Feb. 10, 2004 |
| 6689765 |
Piperazine derivatives useful as CCR5 antagonists |
Feb. 10, 2004 |
| 6689756 |
Treatment of neurological disease |
Feb. 10, 2004 |
| 6683061 |
Enzyme catalyzed therapeutic activation |
Jan. 27, 2004 |
| 6680059 |
Vaccines containing ribavirin and methods of use thereof |
Jan. 20, 2004 |
| 6680292 |
Pharmaceutical composition comprising ribavirin and growth factors and methods of use |
Jan. 20, 2004 |
| 6677310 |
Ring-expanded nucleosides and nucleotides |
Jan. 13, 2004 |
| 6677302 |
Compositions and methods for the treatment of viral disorders |
Jan. 13, 2004 |
| 6673775 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Jan. 6, 2004 |
| 6663859 |
Compositions for enhancing the immune response |
Dec. 16, 2003 |
| 6660719 |
Inhibiting T-Cell proliferation |
Dec. 9, 2003 |
| 6660721 |
Anti-HCV nucleoside derivatives |
Dec. 9, 2003 |
| 6656915 |
Inhibiting T-cell proliferation |
Dec. 2, 2003 |
| 6653290 |
Tumor proliferation inhibitors |
Nov. 25, 2003 |
| 6642206 |
Monocyclic L-nucleosides, analogs and uses thereof |
Nov. 4, 2003 |
| 6632671 |
Nanoparticle encapsulation system and method |
Oct. 14, 2003 |
| 6617315 |
Therapeutic compounds |
Sep. 9, 2003 |
| 6605596 |
Indolocarbazole anticancer agents and methods of using them |
Aug. 12, 2003 |
| 6596725 |
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema |
Jul. 22, 2003 |
| 6593306 |
Methods for modulation and inhibition of telomerase |
Jul. 15, 2003 |
| 6579857 |
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors |
Jun. 17, 2003 |
| 6576621 |
Preparation of thioarabinofuranosyl compounds and use thereof |
Jun. 10, 2003 |
| 6576636 |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
Jun. 10, 2003 |
| 6573248 |
Monocyclic L-nucleosides, analogs and uses thereof |
Jun. 3, 2003 |
| 6573247 |
Anti-viral pyrimidine nucleoside analogues |
Jun. 3, 2003 |
| 6548486 |
Fatty acid esters of nucleoside analogs |
Apr. 15, 2003 |
| 6548241 |
Storage solution containing photosensitizer for inactivation of biological contaminants |
Apr. 15, 2003 |
| 6537974 |
Method of treating arrhythmias |
Mar. 25, 2003 |
| 6518253 |
Treatment of viral infections using the L-isomer of ribavirin |
Feb. 11, 2003 |
| 6518254 |
Ribonucleoside-TRIBOSE |
Feb. 11, 2003 |
| 6509320 |
Purine L-nucleosides, analogs and uses thereof |
Jan. 21, 2003 |
| 6506572 |
Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy |
Jan. 14, 2003 |
| 6495525 |
VLA-4 inhibitor: oMePUPA-V |
Dec. 17, 2002 |
| 6479463 |
Purine L-nucleosides, analogs and uses thereof |
Nov. 12, 2002 |
| 6472373 |
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
Oct. 29, 2002 |
| 6464983 |
Methods and uses of connective tissue growth factor for differentiation of mesenchymal stem cells |
Oct. 15, 2002 |
| 6455507 |
Benzimidazole derivatives |
Sep. 24, 2002 |
| 6455508 |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
Sep. 24, 2002 |
| 6455506 |
Lyxofuranosyl benzimidazoles as antiviral agents |
Sep. 24, 2002 |
| 6440943 |
Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
Aug. 27, 2002 |
| 6440980 |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
Aug. 27, 2002 |
| 6432924 |
Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
Aug. 13, 2002 |
| 6416759 |
Antiproliferative Sgk reagents and methods |
Jul. 9, 2002 |
| 6413938 |
Benzimidazole derivatives for the treatment of viral infections |
Jul. 2, 2002 |
| 6406695 |
Treatment of hepatitis C by administration of anti-IL-2 receptor monoclonal antibody |
Jun. 18, 2002 |
| 6407064 |
Aminoalcohol derivative and medicament comprising the same |
Jun. 18, 2002 |
| 6407069 |
Method for purifying GBS toxin/CM101 |
Jun. 18, 2002 |
| 6403564 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Jun. 11, 2002 |
| 6387365 |
Combination therapy for chronic hepatitis C infection |
May. 14, 2002 |
|
|
|
